School of Medicine, Deakin University, Geelong, Australia.
Department for Management of Science and Technology Development, Ton Duc Thang University, Ho Chi Minh City, Vietnam.
Curr Pharm Des. 2020;26(38):4917-4924. doi: 10.2174/1381612826666200701134135.
It has been well established that solid dispersions have a high potential to increase the release rate of poorly water-soluble drugs, resulting in high drug bioavailability. Solid dispersions have been vigorously investigated with various practical approaches in recent decades. Improvements in wettability, molecular interactions and drugs being held in an amorphous state in solid dispersions are the main mechanisms underlying the high drug release rate. Moreover, the synergistic effect of incorporating nanotechnology in solid dispersions is expected to lead to an advanced drug delivery system for poorly water-soluble drugs. However, to date, there is still a lack of reviews providing outlooks on the nano-sized solid dispersions that have been substantially investigated for improving the bioavailability of poorly water-soluble drugs. In the current review, we aim to overview key advantages and approaches for producing nano-sized solid dispersions. The classification of key strategies in developing nano-sized solid dispersions will advance the creation of even more efficient solid dispersions, which will translate into clinical studies.
已经证实,固体分散体具有提高难溶性药物释放速率的巨大潜力,从而实现高药物生物利用度。在过去几十年中,人们采用了各种实用方法对固体分散体进行了大力研究。固体分散体中改善润湿性、分子相互作用以及使药物保持无定形状态是提高药物释放速率的主要机制。此外,将纳米技术纳入固体分散体的协同作用有望为难溶性药物提供先进的药物传递系统。然而,迄今为止,仍然缺乏对纳米级固体分散体的综述,这些固体分散体在提高难溶性药物生物利用度方面得到了广泛的研究。在本综述中,我们旨在概述生产纳米级固体分散体的关键优势和方法。纳米级固体分散体开发的关键策略分类将推动更高效固体分散体的创造,进而转化为临床研究。